Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Belle Health vs Livea

Belle Health
Graded #48

Higher grade

vs+7.299999999999997
Livea
Graded #115

Lower grade

The verdict

Belle Health takes it — 77/100 to 69.7/100.

Belle Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Belle Health is a national DTC telehealth platform offering compounded semaglutide and tirzepatide with flat-rate pricing — the same monthly cost at every dose, with no escalation surcharge as you titrate up.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBelle Health +38
92
54
Dose & formulationBelle Health +8
72
64
Clinical oversightLivea +22
71
93
Labs & monitoringLivea +1
72
73
FulfillmentBelle Health +6
85
79
Contract termsEven
55
55
Belle Health · left barLivea · right bar

The numbers

MetricBelle HealthLivea
WeighScore77/10069.7/100
GradeC+C
Scorecard rank#48#115
Semaglutide$119/mo$99/mo (plus a separate fee, compounded)
Tirzepatide$199/mo (all doses, 3-month plan, compounded)$199/mo (compounded)
CoverageAll 50 states4 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Belle Health

Graded #48 · C+

Strengths

  • Five named compounding pharmacy partners disclosed (Striker, Strive, OptioRx, Enovex, Braun PharmaCare)
  • Flat-rate pricing — $119/mo semaglutide, $199/mo tirzepatide — doesn't rise at higher doses
  • Free weekly registered-dietitian sessions included
  • Operating since 2017
  • LegitScript Certified

Where it loses points

  • $199 tirzepatide price requires a 3-month bundle commitment
  • Compounded medications are not FDA-approved
  • Multi-pharmacy model — formulations may differ across orders
  • FDA issued this company a warning letter dated 20 February 2026; the letter is public in FDA's warning-letter database
Livea

Graded #115 · C

Strengths

  • LegitScript certified; physician-owned Livea Medical PLLC; Medical Director Dr. Paul Olson, internal medicine/nephrology, 40 years experience
  • Compounded sema from $99/mo and tirz from $199/mo — significantly cheaper than brand Ozempic/Wegovy ($1,000+/mo self-pay)
  • Comprehensive program: InBody scans, registered dietitian nutrition counseling, health coaching, and regular provider check-ins included
  • 15+ years established (founded 2011); 50,000+ clients served; voted Minnesota's Best Weight Loss Program 5 consecutive years
  • Medications shipped to door; same-day consultations; in-person or telehealth; typically HSA/FSA eligible

Where it loses points

  • Telehealth limited to 4 states only (MN, WI, IA, FL) — unavailable to most of the US; primarily a regional clinic network
  • Pricing ambiguous: $69/mo program fee plus separate medication cost ($99/mo sema) may bring GLP-1 total to ~$168/mo
  • Compounded tirzepatide availability uncertain — FDA announced shortage end in 2026; access subject to eligibility
  • Labs (bloodwork) not explicitly included in any published program tier; confirmed at consultation only
  • Strong MN/WI clinic focus; telehealth reach into IA and FL is newer and less established than core markets

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard